Related Experiment Videos
Carcinoid tumors and syndrome
1Ohio State University Medical Center, Endoscopy Lab, Columbus 43210, USA.
Summary
Carcinoid tumors are rare gastrointestinal cancers. Treatment involves surgery for localized tumors and medical support for metastatic disease, with somatostatin analogues managing symptoms.
Area of Science:
- Oncology
- Endocrinology
Background:
- Carcinoid tumors are rare neuroendocrine neoplasms originating primarily in the gastrointestinal tract.
- Tumor malignancy is histologically ambiguous and determined by the presence of metastases.
Observation:
- Carcinoid syndrome, characterized by flushing, diarrhea, and cardiac issues, results from excessive hormone production (e.g., serotonin) by metastatic carcinoid tumors.
- Many tumors are incidentally discovered or present with hormone-related symptoms.
Findings:
- Treatment strategies include surgical resection for primary tumors and palliative medical management for metastatic disease.
- Somatostatin analogues, such as lanreotide and octreotide, are effective in controlling carcinoid syndrome symptoms.
Implications:
- Carcinoid tumors are slow-growing, with patients living up to 30 years post-metastasis diagnosis.
- Understanding carcinoid tumor and syndrome diagnosis, treatment, and patient care is crucial for effective management.